CWA
ABBV icon

Crusonia Wealth Advisors’s AbbVie ABBV Stock Holding History

Crusonia Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$447K Buy
1,775
+568
+47% +$122K 0.07% 149
2026
Q1 		$262K Sell
1,207
-6
-0.5% -$1.33K 0.05% 173
2025
Q4 		$277K Buy
+1,213
New +$276K 0.06% 153

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Crusonia Wealth Advisors's ABBV Position: Q2 2026 in Review

Crusonia Wealth Advisors increased its AbbVie (ABBV) stake by 47% in Q2 2026, buying an estimated $122K and bringing the position to 1,775 shares worth $447K. The position accounts for 0.07% of the portfolio, ranked #149.

Crusonia Wealth Advisors first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Crusonia Wealth Advisors held 1,775 shares of AbbVie worth $447K as of Q2 2026.
  • Crusonia Wealth Advisors bought 568 AbbVie shares in Q2 2026, an estimated $122K.
  • AbbVie made up 0.07% of Crusonia Wealth Advisors's portfolio in Q2 2026, its #149 holding.
  • Crusonia Wealth Advisors first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Crusonia Wealth Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.